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Abstract: COVID-19 vaccine hesitancy poses a threat to the success of vaccination programmes
currently being implemented. Concerns regarding vaccine effectiveness and vaccine-related adverse
events are potential barriers to vaccination; however, it remains unclear whether tailored messaging
and vaccination programmes can influence uptake. Understanding the preferences of key groups,
including students, could guide the implementation of youth-targeted COVID-19 vaccination programmes, ensuring optimal uptake. This study examined university staff and students’ perspectives,
preferences, and drivers of hesitancy regarding COVID-19 vaccines. A multi-methods approach was
used—an online convenience sample survey and discrete choice experiment (DCE)—targeting staff
and students at the University of KwaZulu-Natal, South Africa. The survey and DCE were available
for staff and students, and data were collected from 18 November to 24 December 2021. The survey
captured demographic characteristics as well as attitudes and perspectives of COVID-19 and available
vaccines using modified Likert rating questions adapted from previously used tools. The DCE was
embedded within the survey tool and varied critical COVID-19 vaccine programme characteristics to
calculate relative utilities (preferences) and determine trade-offs. A total of 1836 staff and students
participated in the study (541 staff, 1262 students, 33 undisclosed). A total of 1145 (62%) respondents
reported that they had been vaccinated against COVID-19. Vaccination against COVID-19 was less
prevalent among students compared with staff (79% of staff vs. 57% of students). The vaccine’s effectiveness (22%), and its safety (21%), ranked as the two dominant reasons for not getting vaccinated.
These concerns were also evident from the DCE, with staff and students being significantly influenced
by vaccine effectiveness, with participants preferring highly effective vaccines (90% effective) as
compared with those listed as being 70% or 50% effective (β = −3.72, 95% CI = −4.39 to −3.04); this
characteristic had the strongest effect on preferences of any attribute. The frequency of vaccination
doses was also found to have a significant effect on preferences with participants deriving less utility
from choice alternatives requiring two initial vaccine doses compared with one dose (β = −1.00, 95%
CI = −1.42 to −0.58) or annual boosters compared with none (β = −2.35, 95% CI = −2.85 to −1.86).
Notably, an incentive of ZAR 350 (USD 23.28) did have a positive utility (β = 1.14, 95% CI = 0.76 to
1.53) as compared with no incentive. Given the slow take-up of vaccination among youth in South
Africa, this study offers valuable insights into the factors that drive hesitancy among this population.
Concerns have been raised around the safety and effectiveness of vaccines, although there remains a
predilection for efficient services. Respondents were not enthusiastic about the prospect of having to
take boosters, and this has played out in the roll-out data. Financial incentives may increase both
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the uptake of the initial dose of vaccines and see a more favourable response to subsequent boosters.
Universities should consider tailored messaging regarding vaccine effectiveness and facilitate access
to vaccines, to align services with the stated preferences of staff and students.
Keywords: vaccine hesitancy; youth; South Africa; discrete choice experiment

1. Introduction
More than 181 million infections of SARS-CoV-2 and nearly 4 million deaths from
COVID-19 have been reported as of June 2021 [1]. Although the majority of the risk for
serious illness and death following infection with COVID-19 rests with older populations
and populations with particular co-morbidities, younger people remain highly susceptible to infection and onward transmission [2]. The containment of COVID-19 outbreaks
amongst university students has proved particularly challenging, despite instituting a
number of strategies, including temporary closure and the adoption of online teaching [3].
Although limited, research has revealed that universities, in attempting to reopen, have
experienced a wave of infections, with universities and the surrounding communities
declared COVID-19 hotspots [4]. The availability of vaccines is viewed as an effective tool
with which to control infection and reduce risk, emphasized in May 2020 by the World
Health Assembly. Vaccination is viewed as an important measure to control the COVID-19
global pandemic [5], with research suggesting herd immunity through vaccination to be
the most viable route to achieve epidemic control [6]. However, vaccine hesitancy poses a
threat to the effective global roll-out and uptake of COVID-19 vaccines.
The vast majority of research on the topic of COVID-19 vaccine hesitancy among
youth, and university staff and students, has been conducted in high-income countries,
with very little known and understood about student perceptions, attitudes, acceptance,
and hesitancy of vaccines in Africa [7–12]. As COVID-19 vaccines are being rolled out
globally, there is a need to investigate the determinates of vaccine hesitancy, as well as
vaccine service preferences among youth in different contexts.
As part of a national vaccination strategy to decentralise vaccination sites and make
vaccines more accessible, the University of KwaZulu-Natal (UKZN) in South Africa was
approved as a vaccination site in 2021, with a vaccination campaign launched on the 5th–6th
August targeting staff members and/or students aged 35 years or older, aligned with
the national roll-out strategy, who wished to be vaccinated [13]. The initial two days of
implementation saw a total of 146 individuals getting vaccinated with either the Johnson &
Johnson (J&J) or Pfizer vaccines [13]. Following the adjusted national COVID-19 vaccine
roll-out strategy, eligibility extended to staff and students aged 18 years and above from the
30th of August 2021 [13]. A further 2340 staff and students were vaccinated, representing
only a small proportion of the staff and student body [13]. Although the majority of students
could not access the various university campuses, a total of 17,960 students were residing in
university residences over this period. The goal was to vaccinate at least 200 staff/students
per day, with the capacity of vaccinating up to 1000 staff/students per day. However,
the busiest day saw only 151 vaccinations being administered, with only 16 vaccinations
undertaken on the poorest performing day [13].
South African studies have revealed multiple reasons for COVID-19 vaccine hesitancy and poor vaccine uptake [14,15]. These reasons included vaccines being too new
(34%), concerns about possible side effects (21%), and transparency from the government
regarding the safety and effectiveness of the vaccines (14%). The latter was exacerbated
by the suspension of the initial roll-out of the AstraZeneca vaccine over its effectiveness,
and the J&J vaccine being put on hold temporarily due to concerns about rare clotting
disorders [14].
Although these vaccination strategies may be sufficient for those who already intend
to be vaccinated, for those who remain sceptical and uncertain, it is unclear which specific
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features of vaccination programmes could improve uptake rates, what inducements (such
as mandates or incentives) would further encourage vaccination, or what inherent features
of vaccines (including origin, dosage, or efficacy) would influence decisions to vaccinate.
To explore which vaccine characteristics and implementation features are most important to UKZN staff and students, particularly those who are vaccine-hesitant, we conducted
a survey and discrete choice experiment (DCE) to identify the relative importance of vaccine
characteristics and implementation strategies to determine how best to design vaccination programmes aligned with staff and student preferences to ensure maximal uptake,
lessons which could potentially be applied to higher education institutions throughout
South Africa.
2. Materials and Methods
2.1. Study Design and Setting
A multi-methods approach was carried out, involving an online survey and a DCE,
to determine the prevalence, attitudes, perspectives, and preferences of COVID-19 and
available vaccines among staff and students at UKZN, South Africa. The staff and student
complements at UKZN in 2021 were 4403 and 44,313 respectively [16]. Potential respondents were sent a link to the online questionnaire via email through the internal notice
system, and the data were collected from 18 November to 24 December 2021.
The online questionnaire was developed following a review of similar studies that
evaluated students’ perspectives of, and attitude towards COVID-19 vaccines [17]. A DCE
is a quantitative technique from the field of behavioural economics, used to elicit participant
preferences for goods or services [18–20]. DCEs use stated preference data from a series
of hypothetical choices made by individuals in which they make trade-offs between the
different characteristics (or attributes) of a good or service—in this case, the service delivery
model characteristics and inherent features of COVID-19 vaccines and services. Lancaster’s
Theory of Consumer Choice [21,22] and Random Utility Theory [23] are the theoretical
frameworks that underpin the design and analysis of DCEs, which assume that participants
will make choices that maximise the benefit (or utility) they gain from using a good or
service, and where the total utility an individual gains when making a choice comprises
the utility associated with each of the attributes of the good or service on offer.
The attributes included in this study were initially drawn from a review of previous
COVID-19 DCEs and refined through a series of meetings and discussions with the study
team and key stakeholders at UKZN [24–29]. The final list of attributes and the possible
values each attribute could take (the levels) is illustrated in Table 1.
A fractional factorial design was developed with 32 choice sets using the dcreate
command in STATA, which maximises the D-efficiency of the statistical design using the
modified Fedorov algorithm [30–32]. A blocking variable was included in the design to
divide the 32 choice sets into four versions so that each participant made eight choices
between two hypothetical COVID-19 vaccine models illustrated on a “choice card” (an
example of a choice set is presented in the Supplementary Materials). Each scenario offered
a forced choice (no opt-out), and once participants had made their decision, they were asked
whether they would really get vaccinated if offered the alternative they had just selected.
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Table 1. Discrete choice experiment attributes and levels.
Attribute

Definition

Vaccination location

Location/venues where vaccine
services are provided

Attribute Levels
Government–local clinic or hospital, mobile clinics
Private hospital, family doctor, or pharmacy
At a UKZN vaccination site
1h

Waiting time at vaccination site

Length of time taken to complete the
vaccination process

3h
5h
No fee or incentive

An amount provided as reward for
getting vaccinated

Incentive for vaccination

ZAR 50 (USD 3.33)
ZAR 350 (USD 23.28)

Protection against serious infection
(resulting in hospitalization, ICU
admission, or death

Percentage reduction in serious
disease cases in a vaccinated group of
people

Very effective (90%)
Moderately Effective (70%)
Partially Effective (50%)
USA/North America

Vaccine origin

Country/Region where the vaccine
was developed

UK/Europe
Russia
China

Number of doses

Boosters required

Number of vaccine shots required in
order to complete the regimen

Frequency of additional vaccine
booster shots required

One dose
Two doses
One vaccination provides life-long immunity
(no boosters)
A booster required every 5 years
Annual booster vaccinations required

ZAR 1 = USD 0.0665007: https://www.xe.com/currencyconverter/convert/?Amount=50&From=ZAR&To=USD
(accessed on 23 February 2022).

2.2. Sample Size
Only participants who had not already been vaccinated were eligible to answer the
DCE. Thus, the sample size for the DCE depended on the total number of staff and students
who were willing to take the survey and the vaccination uptake rate in that sample. A
rule of thumb commonly used to determine statistical power for DCEs suggests that the
minimum number of participants per stratification n should be at least 500 ∗ SL∗ J , where L is
the maximum number of levels for any of the alternatives, S is the number of alternatives
in any choice set, and J is the number of choice sets shown to each participant [33].
2.3. Recruitment and Data Collection
The online survey and DCE were administered to a convenience sample of staff and
students at UKZN, a large South African public university. Participants were recruited
through the University’s social media pages and the university’s internal notice system.
Only current staff members and students enrolled at the university at the time of the study
were invited to participate. Survey participants could download a letter of information
which included details of the study objectives, data protection, and confidentiality. Participants were offered compensation in the form of entry into a draw for one of ten ZAR 500
(~USD 33) shopping vouchers; the draw was not linked to participants’ survey responses.
Consent was indicated by participants reading the consent form on the opening page of the
survey and clicking “Agree”, which enabled them to begin answering the survey questions.
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2.4. Data Analysis
All variables were treated as categorical variables. There were two levels of gender
identification (male and female), and two levels of UKZN association (staff and student).
The level of intention to get vaccinated, for participants who identified as unvaccinated, was
grouped as: definitely not (1), probably not (2), probably (3), and definitely (4). COVID-19
vaccine attitudes and COVID-19 perspectives were both grouped as: strongly disagree (1),
disagree (2), indifferent (3), agree (4), and strongly agree (5). COVID-19 vaccine attitudes
and COVID-19 perspectives had a Cronbach’s alpha of 0.9 and 0.7, respectively. Thus,
both scales demonstrated an acceptable internal consistency (Cronbach’s alpha > 0.6) [34].
Data analysis was undertaken using STATA version 17 (Texas, United States of America)
and p-values of <0.05 were considered statistically significant. To determine if there was a
significant difference between the average responses from two groups (staff and students),
t-tests were conducted. The null hypothesis being the difference was equal to zero. The
alternative hypothesis being the difference was not equal to zero. Those who did not give
information about whether they were staff or a student were excluded from the analysis.
The DCE analysis was conducted using a mixed effects logit model to estimate the
relative utility for each attribute and level, where all attribute level coefficients were
modelled as random parameters and 1000 Halton draws were used for the simulation.
Attribute levels were dummy-coded and mean utilities were estimated relative to an
arbitrarily assigned reference level for each attribute (shown in Table 1). Standard deviation
estimates generated by the mixed effects logit model show the magnitude and significance
of any heterogeneity in mean preferences within the sample and give an indication of
where further analysis may be needed to identify sources of heterogeneity.
3. Results
Respondent characteristics were disaggregated by university staff and students (see
Table 2). In total, 1836 respondents completed the survey, the majority (69%) of whom
were students. Table 3 presents data on the number of staff and students who had tested
positive for COVID-19, with reported rates being relatively low, with only 16% of staff
and 12% of students confirming that they had received a positive COVID-19 diagnosis,
with the majority (89%, data not shown) experiencing self-reported mild symptoms. The
majority of staff (79%) and students (57%) had been vaccinated. Of the 555 unvaccinated
respondents, 20.72% declared they would definitely vaccinate, 32.43% stated they would
probably vaccinate, with 27.39% suggesting they would probably not, and 19.46% declaring
they would definitely not vaccinate. The top five statements unvaccinated respondents
selected (data not shown) for not getting vaccinated were; “I do not believe that the vaccine
is effective” (22%), “I do not think the vaccine is safe” (21%), “I have heard/read negative
media about the vaccine” (14%), “Religious reasons” (10%), “Someone else told me they
had a bad reaction to the vaccine” (10%), and “I intend to use traditional or other health
treatments” (9%). Respondents were asked to select which vaccine information sources
they trusted, with the majority (36%) stating healthcare workers (HCWs), followed by
scientific articles (26%). Few respondents sourced trusted information from mainstream
(4%) and social media (0.5%), respectively. Of concern, 15% of respondents stated that they
did not trust any source of information.
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Table 2. Sociodemographic characteristics of respondents by UKZN association.
Characteristic Measures

Staff (N)

Students (N)

Prefer Not to Answer (N)

Male

188 (34.8%)

438 (34.7%)

13 (39.4%)

Female

351 (64.9%)

812 (64.3%)

14 (42.4%)

Other

1 (0.2%)

5 (0.4%)

1 (3%)

Prefer not to answer

1 (0.2%)

7 (0.6%)

5 (15.2%)

<35 years

106 (19.6%)

1140 (90.3%)

15 (45.5%)

35–49 years

230 (42.5%)

104 (8.2%)

9 (27.3%)

50 years or older

204 (37.7%)

14 (1.1%)

5 (15.2%)

Prefer not to answer

1 (0.2%)

4 (0.3%)

4 (12.1%)

African

215 (39.7%)

969 (76.8%)

16 (48.5%)

Coloured

26 (4.8%)

25 (1.9%)

0

Indian

131 (24.2%)

210 (16.6%)

3 (9.1%)

White

137 (25.3%)

28 (2.2%)

7 (21.2%)

Other

6 (1.1%)

9 (0.7%)

1 (3%)

Prefer not to answer

26 (4.8%)

21 (1.7%)

6 (18.2%)

South African

495 (91.5%)

1,176 (93.2%)

24 (72.7%)

Non-South African

44 (8.1%)

78 (6.2%)

3 (9.1%)

Prefer not to answer

2 (0.4%)

8 (0.6%)

6 (18.2%)

Gender

Age

Race

Nationality

Table 3. Prior COVID-19 testing and vaccination among respondents.
Have You Ever Tested Positive for
COVID-19?

Characteristic Measures

Yes

Staff/student

Gender

Age

No

Prefer Not to
Answer

Have You Been Vaccinated for
COVID-19?
Yes

No

Prefer Not to
Answer

Staff

80 (16.4%)

403 (82.8%)

4 (0.8%)

429 (79.3%)

94 (17.4%)

17 (3.1%)

Student

126 (11.9%)

923 (86.8%)

14 (1.3%)

716 (56.7%)

455 (36.1%)

71 (5.6%)

Prefer not to answer

1 (3.6%)

27 (96.4%)

0

18 (54.6%)

6 (18.2%)

7 (21.2%)

Male

69 (12.5%)

476 (86.2%)

7 (1.3%)

385 (60.3%)

208 (32.6%)

36 (5.6%)

Female

137 (13.6%)

862 (85.4%)

11 (1.1%)

767 (65.2%)

343 (29.1%)

55 (4.7%)

Other

0

6 (100%)

0

4 (57.1%)

2 (28.6%)

1 (14.3%)

Prefer not to answer

1 (10%)

9 (90%)

0

7 (53.9%)

2 (15.4%)

3 (23.1%)

<35 years

119 (11.2%)

928 (87.6%)

13 (1.2%)

708 (56.2%)

458 (36.3%)

78 (6.2%)

35-49 years

59 (18.9%)

251 (80.2%)

3 (100%)

250 (72.9%)

77 (22.5%)

11 (3.2%)

50 years or older

29 (14.5%)

170 (85%)

1 (0.5%)

202 (90.6%)

18 (8.1%)

3 (1.4%)

Prefer not to answer

0

4 (80%)

1 (2%)

3 (33.3%)

2 (22.2%)

3 (33.3%)

Table 4 shows staff and student perspectives towards COVID-19 and measures adopted
to mitigate infection. Staff agreed significantly more (M = 2.29, SD = 0.96) than students
(M = 2.14, SD = 0.97) with the statement that they would die if they were infected with
COVID-19, t (1312) = 2.6421, p = 0.008, r = 0.08. Students were significantly more satisfied
(M = 3.84, SD = 1.04) with the measures implemented by UKZN to prevent the spread of
COVID-19, t (1534) = −3.1409, p = 0.001, r = 0.15, than staff (M = 3.66, SD = 1.08). Although
the majority of both staff and students strongly agreed that they could easily wear a mask
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when in public, students were more confident (M = 4.40, SD = 0.97), t (1534) = −2.5610,
p = 0.010, r = −0.14, than staff (M = 4.52, SD = 0.82).
Table 4. COVID-19 perspectives.
COVID-19 Perspective
If I get COVID-19, I could get severe symptoms

If I get severe symptoms, healthcare providers will take care of me

I am worried about getting COVID-19

If I get COVID-19, I will die
I am happy with the measures implemented by the government to
prevent the spread of COVID-19
I am happy with the measures implemented by UKZN to prevent the
spread of COVID-19
I can easily wear a mask when in public

I can easily socially distance when in public

M

SD

Staff

3.28

1.14

Student

3.18

1.17

Staff

3.78

0.92

Student

3.69

1.04

Staff

3.63

1.15

Student

3.55

1.27

Staff

2.29

0.96

Student

2.14

0.97

Staff

3.20

1.16

Student

3.27

1.19

Staff

3.66

1.08

Student

3.84

1.04

Staff

4.40

0.97

Student

4.52

0.82

Staff

4.04

1.08

Student

4.09

1.11

p-Value

r

0.157

−0.05

0.139

−0.17

0.256

0.08

0.008 *

0.08

0.286

0.06

0.001 *

0.15

0.010 *

−0.14

0.433

−0.04

* p < 0.05.

Table 5 reveals staff and student attitudes towards vaccines and vaccine mandates.
While both the majority of staff and students strongly agreed that getting vaccinated was
effective and potentially lifesaving; the greater proportion of staff agreed that vaccines saved
lives, t (1508) = 3.7515, p = 0.000, r = 0.20 and that vaccines were effective, t (1507) = 5.2033,
p = 0.000, r = 0.28. Staff agreed significantly more (M = 3.70, SD = 1.11) than students
(M = 3.51, SD = 1.07) with the statement that pharmaceutical companies had developed safe
and effective COVID-19 vaccines, t (1507) = 3.1246, p = 0.000, r = 0.17. Students (M = 2.85,
SD = 1.04) agreed significantly more than staff (M = 2.67, SD = 1.09) with the statement that
COVID-19 vaccines carried more risks than other vaccines, t (1507) = −3.0654, p = 0.002,
r = −0.17. Staff agreed significantly more (M = 4.05, SD = 1.18) than students (M = 3.84,
SD = 1.18) with the statement that getting vaccinated was a good way to protect their
family from COVID-19, t (1507) = 3.2190, p = 0.001, r = −0.17. Students, however, were
significantly more concerned (M = 3.69, SD = 1.13) than staff (M = 3.14, SD = 1.26) about
serious adverse effects of the COVID-19 vaccine, t (1507) = −8.4494, p = 0.000, r = −0.46.
Although the majority of both staff and students were against mandatory vaccination,
students agreed significantly more (M = 3.91, SD = 1.28) than staff (M = 3.02, SD = 1.45) that
people should not be forced to get vaccinated, t (1507) = −11.9378, p = 0.000, r = −0.66.
Results from the DCE are illustrated in Figure 1, which shows the main effects results
of the mixed effects logit model.
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Table 5. COVID-19 vaccine attitudes.
COVID-19 Vaccine Attitude
Getting vaccinated could save my life

COVID-19 vaccines are effective
Pharmaceutical companies have developed safe and effective
COVID-19 vaccines
Vaccines made in Europe or America are safer than those made in other
countries
COVID-19 vaccines carry more risks than other vaccines
The information I receive about COVID-19 vaccines from Government
is reliable and trustworthy
Getting vaccinated is a good way to protect my family from COVID-19
I would do what my doctor or health care provider recommended about
the COVID-19
I am concerned about serious adverse effects of the COVID-19 vaccine
People should not be forced to get vaccinated

Mean

SD

Staff

4.04

1.20

Student

3.79

1.19

Staff

3.90

1.11

Student

3.58

1.10

Staff

3.70

1.11

Student

3.51

1.07

Staff

2.67

0.97

Student

2.60

0.97

Staff

2.67

1.09

Student

2.85

1.04

Staff

3.28

1.12

Student

3.31

1.09

Staff

4.05

1.18

Student

3.84

1.18

Staff

4.04

1.00

Student

3.98

1.01

Staff

3.14

1.26

Student

3.69

1.13

Staff

3.02

1.45

Student

3.91

1.28

p-Value

r

0.001 *

0.20

0.001 *

0.28

0.001 *

0.17

0.237

0.06

0.002 *

−0.17

0.593

−0.02

0.001 *

0.17

0.295

0.05

0.001 *

−0.46

0.001 *

−0.66

* indicates significance.

Figure 1 shows that, on average, staff and students’ preference structures are significantly
influenced by vaccine effectiveness—participants were far less likely to choose alternatives
with vaccines that were partially effective (at 50%) (β = −3.72, 95% CI = −4.39 to −3.04)
compared with vaccines that were very effective (90%), and this characteristic had the
strongest effect on preferences of any attribute. Participants also derived less utility from
alternatives that were moderately effective (70%) (β = −1.38, 95% CI = −1.84 to −0.91)
compared with alternatives that were very effective (90%). The frequency of boosters was
found to have a significant effect on preferences, with participants deriving less utility
from choice alternatives that required annual boosters (β = −2.35, 95% CI = −2.85 to
−1.86) or boosters every five years (β = −1.22, 95% CI = −1.66 to −0.79) compared with
alternatives that only required one-off vaccination. The influence of the number of boosters
on preferences was stronger than the influence of the number of doses; however, this was
still significant, with participants avoiding alternatives that required two doses (β = −1.00,
95% CI = −1.42 to −0.58) compared with alternatives that required only one dose.
Although a small incentive of ZAR 50 (USD 3.33) did not have a significant effect on
preferences on average, a more generous incentive of ZAR 350 (USD 23.28) was found to
have a positive effect, with participants deriving more utility from alternatives offering a
ZAR 350 incentive (β = 1.14, 95% CI = 0.76 to 1.53) compared with alternatives offering no
incentive. As expected, participants preferred shorter waiting times, deriving less utility
from alternatives that included a five hour waiting time (β = −1.33, 95% CI = −1.77 to
−0.89) or a three hour waiting time (β = −1.30, 95% CI = −1.73 to −0.86) compared with
alternatives with just a one hour waiting time. However, the difference in utility between a
three hour waiting time and five hour waiting time was not found to be significant. On
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and which key sample sub-groups have specific preferences for particular characteristics.
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4. Discussion
This study was undertaken within the context of the slow take-up of vaccination in
South Africa, with only 45% of the adult population, and of concern, only 31% between the
ages of 18 and 23 having been vaccinated as of the 13th of May 2022 [35]. This study aimed
to provide insights into this slow uptake, with a focus on understanding university staff
and student perceptions of COVID-19, along with their attitudes towards and preferences
of COVID-19 vaccines. To fulfil that intent, we adopted a multi-methods approach, utilizing
both a survey and DCE to determine the drivers of hesitancy and potential avenues to
improve vaccination rates, specifically among young adults. Encouragingly, the majority
of university staff and students had been vaccinated; however, aligned with national
and international trends [36,37], vaccination rates were still lowest among students and
individuals under 35 years of age. This could be linked to the supply of vaccines in South
Africa, as has been the case globally, adopting a staggered approach to vaccine roll-out,
initially targeting the older age cohorts and exposed groups, including health workers. At
the time of the study, those aged 18 and older had only been in a position to access vaccines
for three months. Notwithstanding, uptake levels were poor.
The dominant concerns amongst unvaccinated respondents in this study centred
on the vaccine’s safety and effectiveness. These findings mirror other studies that have
explored vaccine hesitancy among students [9,10], and children, adolescents, and young
adults more broadly [37], but offers additional and contextually relevant insights regarding
HCWs as trusted messengers, incentives, the appetite for mandates, and the preference
architecture, all of which could guide future vaccination strategies.
Although the majority of respondents remained concerned about contracting COVID19, only a small proportion were fatalistic about potential infection. Individual’s self-efficacy,
reflected by their ability to adhere to public health measures, specifically mask wearing and
physical distancing, was encouragingly high. Although the risk of severe disease and death
from COVID-19 is lower in young people [35], high infection rates and low vaccination
rates, together with the increased propensity to socialise, means that this cohort remains a
significant vector for transmission [4]. Communication and messaging, in particular, are key
to offset optimism bias, with the need to focus on vaccine safety and effectiveness, and the
wider societal benefits of vaccination in protecting older family members, and vulnerable
friends and colleagues [36]. Gain framed messaging has proved more effective elsewhere
when espousing the benefits of vaccination, including the freedom to attend sporting
events, access to entertainment venues, as well as the ability to travel are reinforced [38].
This research revealed that HCWs were the most trusted source of information, a finding
similar to that found in other studies [39,40]. Understanding how to frame messages to
maximise effect, whilst knowing which sources are considered reliable, remains crucial in
designing communication strategies aimed at young adults.
This study further provides useful insights into which vaccination programme characteristics potentially factor into the decision to vaccinate and how these can be harnessed
to inform vaccine delivery strategies. The results of the DCE showed few trade-offs with
certain vaccine characteristics (effectiveness, incentives, dosage, and the need for boosters), influencing choices. These data are congruent with the survey data, highlighting the
importance of the vaccine’s effectiveness to respondents. The preference for single-dose
vaccines without the requirement for further boosters is further affirmed by South Africa’s
vaccine statistics, which indicate a waning enthusiasm for booster shots [35]. Our evidence
therefore suggests that single-dose vaccines, along with efficient vaccination services and
moderate value incentives (ZAR 350; USD 23.28) could potentially improve vaccination
uptake. Financial incentives have proven effective in encouraging the uptake of vaccines
elsewhere [41–44]. Their feasibility and acceptability, however, are yet to be determined
in the South African context. Future research on the minimum incentive feasibility and
acceptability for financial and non-financial incentives is warranted. Unvaccinated staff
and students remained indifferent to the location of the service and origin of the vaccine.
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The well-being of university staff and students remains paramount, with the recognition that the disruption of education could result in broader social and economic consequences [45]. Many staff and students remain immunologically naïve, raising the spectre of
continued temporary suspension of contact teaching following continued outbreaks. There
remain strong advocates for vaccine mandates in universities [46]; however, this would
need to be carefully implemented, taking into consideration who institutes the mandate
and the consultation process, how to support vaccination, how to deal with exemptions
and non-compliance, and how to evaluate impact which would inform the continuance of
the mandate [47]. Both staff and students were largely unsupportive of vaccine mandates,
revealing the current lack of buy-in for such a strategy.
Taken together, these data offer insights into who the trusted messengers are and what
information, along with which vaccination service characteristics, could influence uptake.
Communication targeting students will need to emphasise the value of getting vaccinated,
and the subsequent need for boosters, whilst elucidating the effectiveness of vaccines and
quelling fears over the vaccine’s potential side-effects. Vaccines will need to be easily
accessible, and service provision efficient. Lastly, this study reveals how incentives could
potentially increase vaccination rates in university settings in South Africa, particularly
among students.
Strengths and Limitations
The survey participants were a convenience sample of staff and students drawn
from one university in the province of KwaZulu-Natal, and thus may not be suitable for
generalizations to be drawn about other university contexts in South Africa. Participation
in this study by staff and students was potentially negatively influenced by the timing of
the study. The study period coincided with the examination period, with most students
no longer accessing university services in December, and many staff taking leave from the
middle of December. However, the sample sizes obtained were nevertheless sufficient to
meet power calculations based on the key outcomes of the study.
We should also be cautious with respect to the conclusions drawn from DCEs, as they
present hypothetical choices to participants, thereby limiting certainty about whether what
participants think they would do would in fact translate into action. Furthermore, none of
the participants in the DCE were already vaccinated; thus, their preferences were based on
perception rather than experience. Although this was a limitation, participants’ perceptions
were likely to ultimately drive action and underpin their decision about whether or not
to vaccinate. DCEs are limited by the attributes that are included in the design. Thus,
there may be other attributes that contribute to utility that were not investigated using this
design (such as issues around vaccine safety). We also asked survey participants to express
their attitudes and preferences towards vaccines at a time when vaccines had not long been
made available, acknowledging that it is possible that both attitudes and preferences will
evolve. Despite these limitations, this research provides data on an important subsection of
the population and provides direct insights for local vaccination strategies. Although these
limitations are important to note, the use of multi-methods helps strengthen the findings
of the study. The DCE data support the findings from the survey, revealing that vaccine
effectiveness is not only a concern, but plays a significant role in determining vaccine
choice behaviour.
5. Conclusions
Understanding university students’ attitudes towards COVID-19 vaccines, together
with their preferences for vaccination services, is important because vaccine uptake among
this cohort remains sub-optimal. This study provides useful insights for the development
of tailored messaging and services targeting young adults, with universities having the
potential to play an important facilitating role in improving vaccine uptake rates among
their staff and students.
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